Last reviewed · How we verify
Guideline Directed Medical Therapy
At a glance
| Generic name | Guideline Directed Medical Therapy |
|---|---|
| Sponsor | Samsung Medical Center |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Sodium-Glucose Cotransporter 2 Inhibitor Use in a National Heart Failure Telemonitoring Program
- Telemedicine-Based Integrated Care for Heart Failure Prevention in Older Patients With Atrial Fibrillation (MIRACLE-AF III) (NA)
- Telemedicine-based Integrated Management of Atrial Fibrillation and Heart Failure in Older Patients in Village Clinics (NA)
- N-of-1 Trial to Promote Beta-Blocker Titration in Heart Failure (NA)
- Medication Withdrawal in Stable HF With Improved LVEF (PHASE2, PHASE3)
- The Impact of Nurse Practitioner-Led Multidisciplinary Team Intervention on the Implementation of Guideline-Directed Medical Therapy and Clinical Outcomes in Adults With Multimorbidity (NA)
- POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure (PHASE2, PHASE3)
- Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Guideline Directed Medical Therapy CI brief — competitive landscape report
- Guideline Directed Medical Therapy updates RSS · CI watch RSS
- Samsung Medical Center portfolio CI